featured
Sequencing T-Cell Redirection Therapies Leads to Deep and Durable Responses in Relapsed/Refractory Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sequencing T-cell redirection therapies leads to deep and durable responses in relapsed/refractory myeloma patients
Blood Adv 2022 Aug 26;[EPub Ahead of Print], TH Mouhieddine, O Van Oekelen, DT Melnekoff, J Li, Y Ghodke-Puranik, G Lancman, S Thibaud, D Pan, S Rajeeve, S Agte, A Aleman, L Sanchez, S Richard, A Rossi, J Richter, HJ Cho, C Rodriguez, A Lagana, EL Moshier, A Chari, S Jagannath, S ParekhFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.